amlodipine and doxazosin

amlodipine has been researched along with doxazosin in 57 studies

Research

Studies (57)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's12 (21.05)18.2507
2000's37 (64.91)29.6817
2010's6 (10.53)24.3611
2020's2 (3.51)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brown, MJ; Dickerson, JE1
Agbedana, EO; Ahaneku, JE; Salako, LA; Taylor, GO; Walker, O1
Cutler, JA; Elmer, PJ; Flack, JM; Grandits, GA; Grimm, RH; McDonald, R; Neaton, JD; Prineas, RJ; Schoenberger, JA; Stamler, J1
Lund-Johansen, P; Omvik, P1
Agbedana, OE; Ahaneku, JE; Taylor, OG1
Elmer, PJ; Flack, J; Grandits, A; Lewis, CE; McDonald, R1
Ahaneku, JE2
Agbedana, EO; Ahaneku, JE; Salako, LA; Sowunmi, A; Taylor, GO; Walker, O1
Elmer, PJ; Flack, JM; Grandits, GA; Grimm, RH; Lewis, CE; Liebson, PR; McDonald, RH; Prineas, RJ; Svendsen, K; Yunis, C1
Gorchein, A1
Fukuzawa, M; Miyaguchi, S; Nakazawa, T; Ohta, S; Qiang, X; Sakata, Y; Satoh, J; Takahashi, K; Takizawa, Y; Toyota, T1
Clark, AL; Cleland, JG; Thackray, S; Witte, K1
Nalbantgil, I; Nalbantgil, S; Onder, R1
Ahn, YK; Bae, Y; Cho, JG; Cho, JH; Jeong, MH; Kang, JC; Kang, KT; Kim, KH; Kim, NH; Kim, SH; Lee, SH; Park, JC; Rhew, JY1
Schillaci, G; Verdecchia, P1
Abe, A; Hosoya, T; Kawamura, Y; Kuriyama, S; Tomonari, H1
Barzilay, JI; Basile, JN; Ciocon, JO; Davis, BR; Goff, DC; Jones, CL; Randall, OS; Sweeney, ME1
Ebbs, D1
Brown, MJ; Deary, AJ; Foo, RS; Haydock, SF; Murfet, H; Schumann, AL1
Ceremuzyński, L; Cybulski, J1
Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F1
Akkaya, V; Celik, AV; Gürol, AO; Hursit, M; Karsidag, K; Kayacan, SM; Yazici, H; Yildiz, A1
Düsing, R2
Wepner, U1
Vidt, DG1
Slany, J1
Kuwajima, I1
Arnett, DK; Black, H; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Miller, MB2
Colon, P; Crow, R; Cutler, JA; Davis, BR; Dunn, K; Ellsworth, A; Franklin, S; Furberg, C; Goff, D; Golden, J; Leenen, F; Mohiuddin, S; Papademetriou, V; Piller, LB; Proschan, M1
Black, HR; Cushman, WC; Davis, BR; Einhorn, PT; Levy, D; Massie, BM; Nwachuku, CE; Piller, LB; Simpson, LM1
Adarraga Cansino, MD; Montijano Cabrera, AM; Rosa Jiménez, F; Zambrana García, JL1
Acikel, C; Caglar, K; Celik, T; Eyileten, T; Oguz, Y; Sonmez, A; Vural, A; Yavuz, I; Yenicesu, M; Yilmaz, MI1
Basar, M; Demirtunc, R; Duman, D1
Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT1
Everett, CM; Lobo, M; Turner, B1
Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Lynch, AI2
Baimbridge, C; Bareis, CJ; Barzilay, J; Basile, JN; Black, HR; Dart, R; Davis, BR; Einhorn, PT; Gupta, AK; Hamilton, BP; Harris-Haywood, S; Haywood, LJ; Jafri, SZ; Louis, GT; Pressel, S; Scott, CL; Simmons, DL; Stanford, C; Whelton, PK; Wright, JT1
Gomi, T; Ikeda, T; Matsuda, N; Shibuya, Y; Shinozaki, S; Suzuki, Y1
Black, HR; Cushman, WC; Davis, BR; Einhorn, PT; Farber, MA; Ford, CE; Kostis, JB; Levy, D; Massie, BM; Nawaz, S; Simpson, LM1
Dobrokhod, AS; Kushnir, SM; Radchenko, GD; Sirenko, YM; Torbas, OO1
Coifman, RR; Coppi, AC; Davis, BR; Dhruva, SS; Furberg, CD; Huang, C; Krumholz, HM; Li, SX; Lin, H; Pressel, SL; Spatz, ES; Warner, F; Xu, X1
Brown, MJ; Caulfield, M; Cruickshank, JK; Ford, I; MacDonald, TM; Mackenzie, IS; McCann, GP; McInnes, G; Morant, S; Padmanabhan, S; Salsbury, J; Sever, P; Webb, DJ; Williams, B1
Davis, BR; Johnson, K; Oparil, S; Tereshchenko, LG1
Böhm, M; Götzinger, F; Hohl, M; Hübner, U; Lauder, L; Lehnert, U; Mahfoud, F; Meyer, MR; Schneider, C; Sevimli, Ö; Tokcan, M; Wagmann, L1
Castagnetti, V; Palazzoli, F; Profeta, C; Santunione, AL; Silingardi, E; Vandelli, D; Verri, P1

Reviews

3 review(s) available for amlodipine and doxazosin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
New drugs for hypertension--variations on old themes.
    Drug and therapeutics bulletin, 1991, Mar-18, Volume: 29, Issue:6

    Topics: Amlodipine; Antihypertensive Agents; Delayed-Action Preparations; Dihydropyridines; Doxazosin; Humans; Hypertension; Isradipine; Nifedipine; Prazosin; Verapamil

1991
[ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3

    Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Doxazosin; Humans; Hypertension; Lisinopril; Male; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Stroke

2004

Trials

31 trial(s) available for amlodipine and doxazosin

ArticleYear
Alpha-blockade and calcium antagonism: an effective and well-tolerated combination for the treatment of resistant hypertension.
    Journal of hypertension, 1995, Volume: 13, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Synergism; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged

1995
Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    JPMA. The Journal of the Pakistan Medical Association, 1994, Volume: 44, Issue:7

    Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Middle Aged

1994
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.
    JAMA, 1993, Aug-11, Volume: 270, Issue:6

    Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Diastole; Double-Blind Method; Doxazosin; Echocardiography; Electrocardiography; Enalapril; Exercise; Female; Follow-Up Studies; Health Behavior; Humans; Hypertension; Long-Term Care; Male; Middle Aged; Treatment Outcome

1993
Relationship between body mass index (BMI) and changes in plasma total and HDL-cholesterol levels during treatment of hypertension in African patients.
    Acta medica Okayama, 1995, Volume: 49, Issue:5

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Black People; Body Mass Index; Cholesterol; Cholesterol, HDL; Doxazosin; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nigeria

1995
Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study.
    Archives of internal medicine, 1996, Feb-26, Volume: 156, Issue:4

    Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Doxazosin; Enalapril; Female; Humans; Hygiene; Hypertension; Life Style; Male; Middle Aged; Nutritional Physiological Phenomena; Patient Education as Topic; Severity of Illness Index; Treatment Outcome

1996
Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    The Kobe journal of medical sciences, 1996, Volume: 42, Issue:1

    Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cross-Over Studies; Doxazosin; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome

1996
Biochemical changes during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    JPMA. The Journal of the Pakistan Medical Association, 1996, Volume: 46, Issue:4

    Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Blood Proteins; Calcium; Creatinine; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Combinations; Electrolytes; Humans; Hydrochlorothiazide; Hypertension; Middle Aged

1996
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
    Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:1 Pt 1

    Topics: Acebutolol; Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Doxazosin; Enalapril; Female; Humans; Hypertension; Libido; Male; Middle Aged; Orgasm; Penile Erection; Sexual Dysfunction, Physiological

1997
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA, 2000, Apr-19, Volume: 283, Issue:15

    Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Survival Analysis

2000
Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
    European journal of heart failure, 2000, Volume: 2, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiotonic Agents; Doxazosin; Heart Failure; Humans; Milrinone; Pyridines; Randomized Controlled Trials as Topic; Thiazepines; Treatment Outcome

2000
Clinically additive effect between doxazosin and amlodipine in the treatment of essential hypertension.
    American journal of hypertension, 2000, Volume: 13, Issue:8

    Topics: Adult; Amlodipine; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged

2000
[Ambulatory blood pressure monitoring in hypertensive CAPD patients].
    Nihon Jinzo Gakkai shi, 2000, Volume: 42, Issue:8

    Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Delayed-Action Preparations; Doxazosin; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory

2000
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Diabetes care, 2001, Volume: 24, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cholesterol, Dietary; Cohort Studies; Coronary Disease; Double-Blind Method; Doxazosin; Ethnicity; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Pravastatin; Racial Groups; Risk Factors; United States

2001
A comparison of selected antihypertensives and the use of conventional vs ambulatory blood pressure in the detection and treatment of hypertension.
    Cardiology, 2001, Volume: 96 Suppl 1

    Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Diastole; Double-Blind Method; Doxazosin; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Systole; Treatment Outcome

2001
Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.
    Journal of hypertension, 2002, Volume: 20, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bendroflumethiazide; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Middle Aged; Natriuretic Peptide, Brain; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors

2002
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:6

    Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed

2002
Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study.
    Clinical nephrology, 2002, Volume: 58, Issue:6

    Topics: Adult; Amlodipine; Antihypertensive Agents; Doxazosin; Female; Homeostasis; Humans; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Pilot Projects; Prospective Studies; Time Factors

2002
The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure.
    Cleveland Clinic journal of medicine, 2003, Volume: 70, Issue:3

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure Determination; Chlorthalidone; Diuretics; Dose-Response Relationship, Drug; Doxazosin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Male; Middle Aged; Patient Compliance; Probability; Risk Assessment; Severity of Illness Index; Treatment Outcome

2003
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
    Circulation, 2005, Jun-28, Volume: 111, Issue:25

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Double-Blind Method; Doxazosin; Female; Follow-Up Studies; Genotype; Humans; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Treatment Outcome

2005
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Circulation, 2006, May-09, Volume: 113, Issue:18

    Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Treatment Outcome

2006
Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study.
    The pharmacogenomics journal, 2007, Volume: 7, Issue:2

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calmodulin-Binding Proteins; Chlorthalidone; Coronary Disease; Double-Blind Method; Doxazosin; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Hypertension; Incidence; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Patient Selection; Polymorphism, Genetic; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Tryptophan

2007
Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Nephrology (Carlton, Vic.), 2007, Volume: 12, Issue:2

    Topics: Adiponectin; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Doxazosin; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Metoprolol; Middle Aged; Predictive Value of Tests; Prospective Studies; Ramipril; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan

2007
Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome: a randomised, controlled study.
    Clinical drug investigation, 2007, Volume: 27, Issue:6

    Topics: Amlodipine; Antihypertensive Agents; Blood Platelets; Doxazosin; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Platelet Count; Prospective Studies; Serotonin

2007
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People

2007
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Archives of internal medicine, 2008, Jan-28, Volume: 168, Issue:2

    Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Black People; Chlorthalidone; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome; White People

2008
Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Circulation, 2008, Nov-25, Volume: 118, Issue:22

    Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Antihypertensive Agents; Coronary Disease; Double-Blind Method; Doxazosin; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; National Heart, Lung, and Blood Institute (U.S.); Prognosis; Risk Assessment; Stroke Volume; Survival Analysis; Survivors; United States

2008
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.
    Pharmacogenetics and genomics, 2012, Volume: 22, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Coronary Disease; Doxazosin; Female; Follow-Up Studies; Genetic Association Studies; Genotype; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Proportional Hazards Models; Risk Factors; Treatment Outcome

2012
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
    Vascular health and risk management, 2013, Volume: 9

    Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Chi-Square Distribution; Diuretics; Doxazosin; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Pulse Wave Analysis; Severity of Illness Index; Time Factors; Treatment Outcome; Ukraine; Vascular Stiffness

2013
Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Hypertension (Dallas, Tex. : 1979), 2017, Volume: 70, Issue:1

    Topics: Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Doxazosin; Drug Monitoring; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Treatment Outcome

2017
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial.
    Journal of the American Heart Association, 2017, Nov-18, Volume: 6, Issue:11

    Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome; Young Adult

2017
Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.
    Journal of the American Heart Association, 2019, 04-16, Volume: 8, Issue:8

    Topics: Aged; Amlodipine; Antihypertensive Agents; Causality; Chlorthalidone; Doxazosin; Electrocardiography; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Linear Models; Lisinopril; Logistic Models; Male; Middle Aged; Personal Protective Equipment; Proportional Hazards Models

2019

Other Studies

23 other study(ies) available for amlodipine and doxazosin

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Cardiovascular drugs and therapy, 1993, Volume: 7, Issue:2

    Topics: Adult; Amlodipine; Antihypertensive Agents; Benzeneacetamides; Carbazoles; Carvedilol; Diet, Sodium-Restricted; Diltiazem; Dipeptides; Doxazosin; Exercise; Felodipine; Female; Hemodynamics; Humans; Hypertension; Ketanserin; Labetalol; Lisinopril; Longitudinal Studies; Male; Middle Aged; Propanolamines

1993
Blood glucose levels in hypertensive patients during treatment with different antihypertensive agents.
    Acta medica Okayama, 1996, Volume: 50, Issue:2

    Topics: Amlodipine; Antihypertensive Agents; Blood Glucose; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged

1996
Drug treatment of hypertension in acute intermittent porphyria: doxazosin and amlodipine.
    British journal of clinical pharmacology, 1997, Volume: 43, Issue:3

    Topics: Amlodipine; Antihypertensive Agents; Doxazosin; Drug Monitoring; Female; Humans; Hypertension; Middle Aged; Porphyria, Acute Intermittent

1997
Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs.
    Immunopharmacology, 2000, Volume: 48, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Diuretics; Doxazosin; Humans; Hydrochlorothiazide; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Metoprolol; Mice; Mice, Inbred BALB C; Monocytes; Nicardipine; Nitrobenzenes; Piperazines; Sodium Chloride Symporter Inhibitors; Tumor Necrosis Factor-alpha

2000
Successful management of intractable coronary spasm with a coronary stent.
    Japanese circulation journal, 2000, Volume: 64, Issue:11

    Topics: Adult; Amlodipine; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vasospasm; Diltiazem; Doxazosin; Drug Resistance; Drug Therapy, Combination; Ergonovine; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Nicorandil; Nitrates; Pyridines; Stents; Ticlopidine; Ventricular Fibrillation

2000
[Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:9

    Topics: Adrenergic alpha-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Canada; Chlorthalidone; Coronary Disease; Diuretics; Doxazosin; Humans; Hypertension; Lisinopril; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk; United States

2000
[Hypertension and metabolic syndrome in population of one company. Monotherapy with amlodipine and doxazosin].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:73

    Topics: Adult; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure; Doxazosin; Female; Humans; Hypertension; Incidence; Male; Metabolic Syndrome; Middle Aged; Poland; Time Factors; Treatment Outcome

2002
[Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
    Deutsche medizinische Wochenschrift (1946), 2003, Jan-31, Volume: 128, Issue:5

    Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Diuretics; Doxazosin; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Research Design; Treatment Outcome

2003
[Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!].
    MMW Fortschritte der Medizin, 2003, Jan-16, Volume: 145, Issue:1-2

    Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Doxazosin; Humans; Hypertension; Lisinopril; Middle Aged; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors

2003
Diuretics: older, cheaper, better.
    The Johns Hopkins medical letter health after 50, 2003, Volume: 15, Issue:2

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Diuretics; Doxazosin; Humans; Hypertension; Lisinopril; Middle Aged; Sodium Chloride Symporter Inhibitors

2003
[ALLHAT: Old Hat Hits All? On selection of the optimal antihypertensive drug].
    Wiener klinische Wochenschrift, 2003, Mar-31, Volume: 115, Issue:5-6

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cause of Death; Chlorthalidone; Dose-Response Relationship, Drug; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Long-Term Care; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome

2003
[The new (old) knowledge in primary prevention of stroke. It depends on lowering of blood pressure].
    MMW Fortschritte der Medizin, 2003, Volume: 145 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Doxazosin; Follow-Up Studies; Heart Failure; Humans; Lisinopril; Middle Aged; Myocardial Infarction; Primary Prevention; Stroke; Time Factors

2003
[ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
    MMW Fortschritte der Medizin, 2005, Sep-29, Volume: 147, Issue:39

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Doxazosin; Drug Therapy, Combination; Follow-Up Studies; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Sodium Chloride Symporter Inhibitors; Treatment Outcome

2005
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
    American heart journal, 2007, Volume: 153, Issue:1

    Topics: Adrenergic alpha-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Comorbidity; Double-Blind Method; Doxazosin; Female; Heart Failure; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Research Design; Sodium Chloride Symporter Inhibitors

2007
[Recurrent syncopes secondary to pheochromocytoma].
    Medicina clinica, 2007, Feb-24, Volume: 128, Issue:7

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Aged; Amlodipine; Antihypertensive Agents; Doxazosin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Pheochromocytoma; Radiography, Abdominal; Recurrence; Syncope; Time Factors; Tomography, X-Ray Computed; Vasodilator Agents

2007
Posterior reversible encephalopathy syndrome in (low renin) essential hypertension.
    Journal of the Royal Society of Medicine, 2007, Volume: 100, Issue:11

    Topics: Adult; Amlodipine; Antihypertensive Agents; Doxazosin; Drug Therapy, Combination; Female; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Renin; Renin-Angiotensin System; Seizures; Syndrome; Treatment Outcome

2007
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
    JAMA, 2008, Jan-23, Volume: 299, Issue:3

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Diuretics; Doxazosin; Female; Genotype; Humans; Hypertension; Lisinopril; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide

2008
Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:11

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Blood Pressure; Cholesterol; Doxazosin; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Time Factors; Triglycerides

2007
Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats.
    Hypertension (Dallas, Tex. : 1979), 2023, Volume: 80, Issue:6

    Topics: Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Bisoprolol; Blood Pressure; Cardiomyopathies; Denervation; Doxazosin; Hydrochlorothiazide; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Renin; Sympathectomy

2023
Cardiovascular drugs and suicide death: Determination of carvedilol, amlodipine, doxazosin and diltiazem in two fatal cases.
    Journal of pharmaceutical and biomedical analysis, 2024, Jan-20, Volume: 238

    Topics: Amlodipine; Cardiovascular Agents; Carvedilol; Diltiazem; Doxazosin; Humans; Suicide

2024